Back

Clonal hematopoiesis of indeterminate potential in atrial fibrillation: prevalence and an association with progression

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Pathophysiology and mechanisms of atrial fibrillation Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Hyojeong Ahn

Seoul National University Hospital, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Changes in ubiquitylated proteins in atrial fibrillation associated with heart valve disease: proteomics in human left appendage tissue
Doctor Y. Xiao (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Serum magnesium and phosphorus values are lower among patients with paroxysmal atrial fibrillation: insights from the PLACEBO study
Mrs A. Boulmpou (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Local changes in conduction velocity in the left atrium of atrial fibrillation patients undergoing pulmonary vein isolation
Ms I. Meijer (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Soluble ST2 biomarker utility in the comprehension of the clinical course of atrial fibrillation
Doctor L. Gonzalez-Melchor (Arrecife, Las Palmas, ES)
Abstract Slides Video
Presentation thumbnail
Snoring and lack of REM sleep is associated with same-day atrial arrhythmias in a cohort of patients with atrial fibrillation: initial results of TriggersAF
Doctor J. Bacevicius (Vilnius, LT)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology and mechanisms of atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Presentation
Atrial arrhythmias
thumbnail
Congress Session
Basic science and arrhythmia pathophysiology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources